Citation Impact
1 from Science/Nature 59 standout
Citing Papers
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
2024 Standout
Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer
2024 Standout
Works of Jérôme Rapion being referenced
Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3‐98
2013
Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
2010
Author Peers
| Author | Molecular Biology | Oncology | PHEOH | Cell Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Jérôme Rapion | 65 | 82 | 31 | 53 | 5 | 156 | |
| David J. Rexing | 24 | 1 | 4 | 15 | 1.2k | ||
| Chunling Yu | 13 | 1 | 21 | 404 | |||
| Fumito Fujishiro | 2 | 64 | 610 | ||||
| Nathan G. Greeneltch | 318 | 1 | 7 | 12 | 1.0k | ||
| Ran Yahalom | 305 | 843 | 13 | 54 | 73 | 1.7k |
All Works
Loading papers...